ACT Methylphenidate ER (2020-02-07)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
ACT Methylphenidate ER 18 mg Tablet
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| 1293319A | ACT Methylphenidate ER 18 mg Tablet | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court
- Toronto
- M1B 2K9
- Ontario
- CANADA
| DIN 02441934 | Tablet (Extended-Release) | Methylphenidate hydrochloride 18 mg |
Affected lot(s) may be missing the desiccant.
Wholesalers, Healthcare Establishments, Retailers